• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EV1
Click for more information
0.00% 3.4¢

EVOLUTION ENERGY MINERALS LIMITED - Charts / Financials

Market Cap $12.25M  ! watchlist Created with Sketch. Add to my watchlist
Metals & Mining Industrial Metals & Minerals

Evolution Energy Minerals Limited is an Australia-based company, which is involved in... Evolution Energy Minerals Limited is an Australia-based company, which is involved in exploration and pre-development works. The Company is engaged in the exploration and development of its Chilalo Graphite Project in southern Tanzania. The Company has discovered two high-grade mineralized zones, Chilalo East and Chilalo E2. High-grade mineralization at Chilalo East has been defined over 1.6 kilometers (km) out of a potential 3.5 km strike length indicated by the high-conductance electromagnetic conductor. At Chilalo E2, located to the east of Chilalo Mining License and parallel to the north of Chilalo East, 1.1 km out of a potential five km strike has been tested so far with mineralization open to the east and west.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 14.06pm 03/10/2024 (20 minute delay) ?
Day
Open 3.5¢   Day High 3.5¢   Day Low 3.4¢
Daily Volume 103720
Bids   Sellers
Number Price Volume   Number Price Volume
2 3.4¢ 243688   1 3.9¢ 91357

Data source: Refinitiv

(20min delay)
Last
3.4¢ 		Change
0.000(0.00%) 		Mkt cap ! $12.25M
Open High Low Value Volume
3.5¢ 3.5¢ 3.4¢ $3.585K 103.7K

Buyers (Bids)

No. Vol. Price($)
2 243688 3.4¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 91357 1
View Market Depth
Last trade - 11.55am 03/10/2024 (20 minute delay) ?
Last
3.4¢ 		  Change
0.000 ( 2.86 %)
Open High Low Volume
3.4¢ 3.4¢ 3.4¢ 43280
Last updated 14.06pm 03/10/2024 ?

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
The Breakdown: Lithium Universe talks financial modelling and lithium pricing in strong preliminary feasibility study for Bécancour Lithium Universe Ltd is helping investors understand its recent prefeasibility study for a lithium plant in Quebec with a series of videos
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
ASX Market Open: Middle East tensions push oil higher and Wall Street lower, reverberating on the ASX200 | October 4, 2024 Negative sentiment in US markets amid tensions in the Middle East have been felt on the Australian bourse, with the ASX200 opening lower
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.